Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Kezar Life Sciences Total Assets (Quarterly) : 68.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 68.00M |
| December 31, 2025 | 76.65M |
| September 30, 2025 | 97.73M |
| June 30, 2025 | 109.12M |
| March 31, 2025 | 125.26M |
| December 31, 2024 | 144.68M |
| September 30, 2024 | 164.09M |
| June 30, 2024 | 179.92M |
| March 31, 2024 | 199.13M |
| December 31, 2023 | 221.24M |
| September 30, 2023 | 249.33M |
| June 30, 2023 | 263.38M |
| March 31, 2023 | 284.18M |
| December 31, 2022 | 299.57M |
| September 30, 2022 | 304.77M |
| June 30, 2022 | 317.50M |
| March 31, 2022 | 251.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 217.93M |
| September 30, 2021 | 130.89M |
| June 30, 2021 | 139.67M |
| March 31, 2021 | 152.34M |
| December 31, 2020 | 151.84M |
| September 30, 2020 | 161.21M |
| June 30, 2020 | 168.32M |
| March 31, 2020 | 134.64M |
| December 31, 2019 | 89.51M |
| September 30, 2019 | 97.52M |
| June 30, 2019 | 105.27M |
| March 31, 2019 | 113.06M |
| December 31, 2018 | 114.68M |
| September 30, 2018 | 120.27M |
| June 30, 2018 | 125.67M |
| March 31, 2018 | 54.25M |
| December 31, 2017 | 54.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Protara Therapeutics, Inc. | 176.09M |
| Clene, Inc. | 23.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.762M |
| Shareholders Equity (Quarterly) | 65.24M |
| Debt to Equity Ratio | 0.0208 |
| Current Ratio | 24.46 |
| Net Debt Paydown Yield | 5.42% |